Physician profile
Sergio Rodriguez
NPI 1205370160
$1,010.47
in general payments reported to CMS, 2019-2025
14 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.07 · 2023: $211 · 2024: $268 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $991.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $380.97 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.03 | 2024-2025 | Jardiance |
| Pfizer INC. | $97.50 | 2024-2025 | |
| Glaxosmithkline, LLC. | $47.23 | 2023 | Arexvy, Shingrix |
| Amgen INC. | $42.76 | 2023-2024 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $39.50 | 2024-2025 | |
| Exact Sciences Corporation | $38.47 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Dynavax Technologies Corporation | $38.36 | 2023 | Heplisav-B |
| Merck Sharp & Dohme LLC | $30.29 | 2025 | Capvaxive, Vaxneuvance, Gardasil 9 |
| Abbvie INC. | $24.37 | 2024 | |
| Medtronic, INC. | $16.92 | 2025 | Venaseal |
| Xeris Pharmaceuticals, INC. | $14.00 | 2023 | Gvoke Hypopen |
| Organon LLC | $11.82 | 2021 | |
| Genentech USA, INC. | $7.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.